Perennial Investment Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.75M Buy
1,901
+38
+2% +$38.5K 0.14% 124
2025
Q4
$2M Buy
1,863
+68
+4% +$65K 0.16% 111
2025
Q3
$1.37M Sell
1,795
-73
-4% -$54.3K 0.11% 149
2025
Q2
$1.46M Buy
1,868
+57
+3% +$44.3K 0.14% 135
2025
Q1
$1.5M Buy
1,811
+254
+16% +$211K 0.17% 110
2024
Q4
$1.2M Buy
1,557
+172
+12% +$142K 0.14% 127
2024
Q3
$1.23M Buy
1,385
+48
+4% +$43.2K 0.16% 106
2024
Q2
$1.21M Buy
1,337
+124
+10% +$99.2K 0.17% 104
2024
Q1
$943K Buy
1,213
+215
+22% +$153K 0.14% 115
2023
Q4
$582K Buy
998
+65
+7% +$37.9K 0.1% 162
2023
Q3
$501K Sell
933
-9
-1% -$4.64K 0.09% 175
2023
Q2
$442K Buy
942
+43
+5% +$18K 0.08% 194
2023
Q1
$309K Buy
+899
New +$303K 0.06% 233

Other funds holding LLY

Perennial Investment Advisors's LLY Position: Q1 2026 in Review

Perennial Investment Advisors increased its Eli Lilly (LLY) stake by 2% in Q1 2026, buying an estimated $38.5K and bringing the position to 1,901 shares worth $1.75M. The position accounts for 0.14% of the portfolio, ranked #124.

Perennial Investment Advisors first reported a position in LLY in Q1 2023 and has held it in 13 quarters since. The position peaked at $2M in Q4 2025. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Perennial Investment Advisors held 1,901 shares of Eli Lilly worth $1.75M as of Q1 2026.
  • Perennial Investment Advisors bought 38 Eli Lilly shares in Q1 2026, an estimated $38.5K.
  • Eli Lilly made up 0.14% of Perennial Investment Advisors's portfolio in Q1 2026, its #124 holding.
  • Perennial Investment Advisors first reported a position in Eli Lilly in Q1 2023 and has held it in 13 quarters since.
  • Perennial Investment Advisors's Eli Lilly position peaked at $2M in Q4 2025.
  • 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Perennial Investment Advisors's 13F filing for Q1 2026, filed 15 May 2026.